LZTR1 and cardiac hypertrophy: Conversely, the mTOR signaling pathway was suppressed in Lztr1R409C/+ mice, and rapamycin treatment did not rescue LZTR1 mutation–dependent cardiac hypertrophy (Figure 5 and Figure 6).